Health Care Analysis

, Volume 12, Issue 2, pp 91–115 | Cite as

Fair Drug Prices and the Patent System

  • David B. Resnik

Abstract

This paper uses John Rawls' theory of justice to defend the patent system against charges that it has an unfair effect on access to medications, from the perspective of national and international justice. The paper argues that the patent system is fair in a national context because it respects intellectual property rights and it benefits the least advantaged members of society by providing incentives for inventors, investors, and entrepreneurs. The paper also argues that the patent system is fair in an international context, provided that developed nations take steps to help disease-stricken countries secure internal justice. Fairness in a national or international context also requires that the patent system should include emergency exceptions to deal with short-term inequities.

pharmaceutical patents justice fairness John Rawls TRIPS agreement HIV/AIDS developing nations 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Angell, M. (2000) The Pharmaceutical Industry—To Whom is it Accountable? The New England Journal of Medicine 342, 1902–1904.Google Scholar
  2. Beitz, C. (1998) International Justice: Conflict. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 2), pp. 871–874. New York: Academic.Google Scholar
  3. Beitz, C. (1999) Political Theory and International Relations, (2nd ed.). Princeton, NJ: Princeton University Press.Google Scholar
  4. Best-Online Pharmacy.com. (2003) Amoxycillin. Available at: http://www.best-online-pharmacies. com/prescription-drugs/prescription-drugs-amoxycillin.htmlGoogle Scholar
  5. Bian, T. (1997) The Drug Lords: America's Pharmaceutical Cartel. New York: No Barriers.Google Scholar
  6. Bildt, C. (2003, January 7) Fight Poverty, Not Patents. The Wall Street Journal, p. A13.Google Scholar
  7. Blustein, P. (2003, February 1) Activists Hail President's Call for More Funding to Fight AIDS. The Washington Post, pp. A12.Google Scholar
  8. Bodenheimer, T. (2000) Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry. The New England Journal of Medicine 342, 1539–1544.Google Scholar
  9. Brody, B. (1995) Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press.Google Scholar
  10. Brody, B. (1996) Public Goods and Fair Prices: Balancing Technological Innovation and Social Well Being. Hastings Center Report 26(2), 5–11.Google Scholar
  11. Daniels, N. (1984) Just Health Care. Cambridge, UK: Cambridge University Press.Google Scholar
  12. Diller, L. (1996) The Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s. Hastings Center Report 26(2), 12–18.Google Scholar
  13. Dworkin, G. (1988) The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press.Google Scholar
  14. Enserink, M. (2003) Bill Gates Plans a Hit List, with NIH's Help. Science 299, 641.Google Scholar
  15. Goldhammer, A. (2001) Current Issues in Clinical Research and the Development of New Pharmaceu-ticals. Accountability in Research 8, 283–291.Google Scholar
  16. Gutmann, A., and Thompson, D. (1996) Democracy and Disagreement. Cambridge, MA: Harvard University Press.Google Scholar
  17. Harsanyi, J. (1975) Can the Maximin Principle Serve as a Basis for Morality? American Political Science Review 69, 594–606.Google Scholar
  18. Harsanyi, J. (1976) Essays on Ethics, Social Behavior, and Scientific Explanation. Dordrecht, The Netherlands: Reidel.Google Scholar
  19. Headden, S. (1997, September 1) The Big Pill Push. U.S. News and World Report, pp. 67–71.Google Scholar
  20. Hewitt, W. (1967) Penicillin: Historical Impact on Infection Control. Annals of the New York Academy of Sciences 145, 212–215Google Scholar
  21. King, R. (1997, Winter/Spring) The Evolution of Today's Calculator. International Calculator Col-lector 15/16, p. 1, 4. Available at: http://www.vintagecalculators.com/html/evolutionoftoday's-calculato. htmlGoogle Scholar
  22. Lacayo, A. (2003) Seeking a Balance: International Pharmaceutical Patent Protection, Public Health Crises, and the Emerging Threat of Bio-terrorism. University of Miami International-American Law Review 33, 295–321.Google Scholar
  23. Loff, B. (2002) World Trade Organization Wrestles with Access to Cheap Drugs Solution. The Lancet 360, 1670.Google Scholar
  24. Manzer, J. (2002) Is Canada American's Favorite Drugstore? Medical Post 38(46), 1–5.Google Scholar
  25. Marsa, L. (1999) Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Unholy Marriage Between Science and Business. New York: Scribner. Mill, J.S. (1861 [1979]) Utilitari-anism. Indianapolis, IN: Hackett.Google Scholar
  26. Miller, A., and Davis, M. (2000) Intellectual Property. St. Paul, MN: West.Google Scholar
  27. Nerozzi, M. (2002) The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being ‘TRIPped’ by Developed Countries? Villanova Law Review 47, 605–641.Google Scholar
  28. Nozick, R. (1974) Anarchy, State, and Utopia. New York: Basic.Google Scholar
  29. Obsolete Technology Website. (2003) Apple III. Available at: http://oldcomputers.net/appleiii.htmlGoogle Scholar
  30. O'Neill, O. (1998) International Justice: Distribution. In R. Chadwick, (Ed.)., Encyclopedia of Applied Ethics, (Vol. 2), pp. 874–877. New York: Academic.Google Scholar
  31. Pear, R. (2002, December 25) Law Requiring Lower Drug Prices in Struck Down. The New York Times, p. A1.Google Scholar
  32. Pear, R. (2003, January 3) Bush May Link Drug Benefit in Medicare to Private Plans. The New York Times,p.A1.Google Scholar
  33. Pharmaceutical Research and Manufacturing Association (PhRMA). (2003a) Research and Develop-ment. Washington, DC: PhRMA. Available at: www.phrma.orgGoogle Scholar
  34. Pharmaceutical Research and Manufacturing Association (PhRMA). (2003b) Intellectual Property. Washington, DC: PhRMA. Available at: www.phrma.orgGoogle Scholar
  35. Plato. (1974 [circa 400 BC]) The Republic. (G. Grube, (transl). Indianapolis, IN: Hackett.Google Scholar
  36. Rawls, J. (1971) A Theory of Justice. Cambridge, MA: Harvard University Press.Google Scholar
  37. Rawls, J. (1993) Political Liberalism. New York: Columbia University Press.Google Scholar
  38. Rawls, J. (1999) The Law of the Peoples. Cambridge, MA: Harvard University Press.Google Scholar
  39. Rawls, J. (2002) Justice As Fairness: A Restatement. E. Kelly, (Ed.). Cambridge, MA: Harvard Uni-versity Press.Google Scholar
  40. Reich, M. (2000) The Global Drug Gap. Science 287, 1979–1981.Google Scholar
  41. Resnik, D. (2001) Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma. Developing World Bioethics 1,11–32.Google Scholar
  42. Resnik, D., and De Ville, K. (2002) Bioterrorism and Patent Rights: Compulsory Licensure and the Case of Cipro. American Journal of Bioethics 2(3), 29–39.Google Scholar
  43. Resnik, M. (1987) Choice: An Introduction to Decision Theory. Minneapolis: University of Minnesota Press.Google Scholar
  44. Samuelson, P. (1980) Economics (11th ed.). New York: McGraw-Hill.Google Scholar
  45. Sandel, M. (1982) Liberalism and the Limits of Justice. Cambridge, UK: Cambridge University Press.Google Scholar
  46. Schaafsma, P. (1997) An Economic Overview of Patents. Journal of the Patent and Trademark Office Society 79, 241–257.Google Scholar
  47. Shamoo, A., and Resnik, D. (2002) Responsible Conduct of Research. New York: Oxford University Press.Google Scholar
  48. Singer, P. (1972) Famine, Affluence, and Morality. Philosophy and Public Affairs 1, 229–243.Google Scholar
  49. Stolberg, S. (2003, February 2) The White House Gets Religion on AIDS in Africa. The New York Times,p.A1.Google Scholar
  50. Stolberg, S., and Gerth, J. (2000, April 23) Medicine Merchants: Holding Down the Competition. The New York Times,p.A1.Google Scholar
  51. U.S. Constitution. (1787) Article 1, Section 8, Clause 8.Google Scholar
  52. Wreen, M. (1998) Patents. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 3), New York: Academic. pp. 435–447.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • David B. Resnik
    • 1
  1. 1.The Bioethics Center, Department of Medical HumanitiesThe Brody School of Medicine, East Carolina UniversityGreenvilleNorth Carolina

Personalised recommendations